EAPIN Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Conservative LeverageLow leverage provides Euroapi with financial flexibility while it addresses operational challenges. A modest debt burden can reduce interest and refinancing pressure, preserve capacity for investment in API manufacturing, and improve resilience if customer demand or profitability remains uneven over the next several quarters.
Improved Cash GenerationThe return to positive operating and free cash flow indicates that the business has recently converted operations into cash despite weak reported earnings. This supports ongoing manufacturing needs and strategic investment, while providing a more tangible funding base than relying solely on external capital.
EBITDA Margin ReboundThe EBITDA margin recovery suggests that underlying operating profitability improved even as revenue declined. If sustained, stronger operating economics could help Euroapi absorb fixed manufacturing costs, support cash generation, and create a foundation for restoring bottom-line profitability over the medium term.
Bears Say
Declining RevenueTwo consecutive years of declining revenue point to pressure on commercial volumes or customer demand rather than a single-quarter fluctuation. Continued top-line contraction would reduce capacity utilization, limit operating leverage, and make it harder for Euroapi to sustain margin improvements across its API platform.
Widening Net LossesPersistent and materially widening net losses weaken the company’s ability to build equity and fund growth internally. They also show that improved EBITDA has not yet translated into sustainable bottom-line earnings, leaving Euroapi exposed to continued charges or non-operating costs that could delay a full recovery.
Volatile Cash ConversionAlthough recent cash flow is positive, the prior period of negative free cash flow and the sharp deterioration in reported 2025 growth indicate inconsistent cash conversion. Such volatility can complicate capital planning, constrain investment in manufacturing capabilities, and increase dependence on operational execution to preserve liquidity.
Euroapi SA News
EAPIN FAQ
What was Euroapi SA’s price range in the past 12 months?
Currently, no data Available
What is Euroapi SA’s market cap?
Euroapi SA’s market cap is $1.43B.
When is Euroapi SA’s upcoming earnings report date?
Euroapi SA’s upcoming earnings report date is Mar 09, 2027 which is in 158 days.
How were Euroapi SA’s earnings last quarter?
Euroapi SA released its earnings results on Jul 29, 2026. The company reported -$29.426 earnings per share for the quarter.
Is Euroapi SA overvalued?
According to Wall Street analysts Euroapi SA’s price is currently Undervalued.
Does Euroapi SA pay dividends?
Euroapi SA does not currently pay dividends.
What is Euroapi SA’s EPS estimate?
Euroapi SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Euroapi SA have?
Euroapi SA has 96,010,155 shares outstanding.
What happened to Euroapi SA’s price movement after its last earnings report?
Euroapi SA reported an EPS of -$29.426 in its last earnings report. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Euroapi SA?
Currently, no hedge funds are holding shares in MX:EAPIN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Euroapi SA
Headquartered in Paris, France, Euroapi SA, founded in 2021, specializes in the research, production, promotion, and delivery of active pharmaceutical ingredients (APIs) and chemical intermediates. These vital components are utilized in the development of both human and animal medical treatments.